Opko Health, Inc. financial data

Symbol
OPK on Nasdaq
Industry
Pharmaceutical Preparations
Location
4400 Biscayne Blvd., Miami, FL
State of incorporation
Delaware
Fiscal year end
December 31
Former names
EXEGENICS INC (to 6/13/2007), eXegenics Inc (to 6/13/2007), CYTOCLONAL PHARMACEUTICS INC /DE (to 6/4/2001)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 172 % -3.16%
Quick Ratio 30.8 % -2.75%
Debt-to-equity 46.3 % +19.1%
Return On Equity -18 % -163%
Return On Assets -12.1 % -26.3%
Operating Margin -37.2 % -93.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 697M shares -9.79%
Entity Public Float 904M USD -14.8%
Common Stock, Value, Issued 7.27M USD -6.96%
Weighted Average Number of Shares Outstanding, Basic 697M shares -7.25%
Weighted Average Number of Shares Outstanding, Diluted 752M shares +13.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 716M USD -17.5%
Research and Development Expense 84.8M USD -4.76%
Operating Income (Loss) -267M USD -60%
Nonoperating Income (Expense) 22M USD
Income Tax Expense (Benefit) -1.57M USD +97%
Net Income (Loss) Attributable to Parent -243M USD -16.2%
Earnings Per Share, Basic -0.33 USD/shares -22.2%
Earnings Per Share, Diluted -0.38 USD/shares -111%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 40.6M USD -62.5%
Accounts Receivable, after Allowance for Credit Loss, Current 105M USD -50.1%
Inventory, Net 60.2M USD -18.4%
Other Assets, Current 6.73M USD -6.62%
Assets, Current 358M USD -17.5%
Property, Plant and Equipment, Net 66.8M USD -15.4%
Operating Lease, Right-of-Use Asset 61.6M USD +76.4%
Intangible Assets, Net (Excluding Goodwill) 659M USD -15.7%
Goodwill 530M USD -11.3%
Other Assets, Noncurrent 7.8M USD -12.8%
Assets 1.98B USD -8.29%
Accounts Payable, Current 82.2M USD -6.41%
Accrued Liabilities, Current 94.5M USD -4.15%
Contract with Customer, Liability, Current 0 USD
Liabilities, Current 220M USD -3.05%
Contract with Customer, Liability, Noncurrent 7K USD -95%
Deferred Income Tax Liabilities, Net 119M USD -10.5%
Operating Lease, Liability, Noncurrent 49.6M USD +99.2%
Other Liabilities, Noncurrent 20.3M USD -24.3%
Liabilities 585M USD -6.25%
Accumulated Other Comprehensive Income (Loss), Net of Tax -46.7M USD -26.3%
Retained Earnings (Accumulated Deficit) -2.1B USD -13.1%
Stockholders' Equity Attributable to Parent 1.4B USD -9.12%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.55B USD -3.91%
Liabilities and Equity 1.98B USD -8.29%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.6M USD -57%
Net Cash Provided by (Used in) Financing Activities 20.6M USD
Net Cash Provided by (Used in) Investing Activities -4.4M USD +43%
Common Stock, Shares Authorized 1.25B shares +25%
Common Stock, Shares, Issued 727M shares -6.97%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -20.2M USD +52.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 40.6M USD -62.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.13M USD -18.4%
Deferred Tax Assets, Valuation Allowance 295M USD +5.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 282M USD +6.56%
Operating Lease, Liability 61.2M USD +69.4%
Depreciation 17.4M USD -12.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -253M USD -28.3%
Lessee, Operating Lease, Liability, to be Paid 73.8M USD +81.1%
Operating Lease, Liability, Current 11.6M USD +3.42%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.4M USD +86.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.2M USD +26.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +21.7%
Deferred Income Tax Expense (Benefit) -2.68M USD -2727%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.5M USD +173%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10.2M USD +148%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 16.9M USD +14.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.99M USD +159%
Operating Lease, Payments 4.33M USD +11.9%
Additional Paid in Capital 3.54B USD +3.31%
Amortization of Intangible Assets 84.9M USD -1.27%
Depreciation, Depletion and Amortization 102M USD -3.07%
Share-based Payment Arrangement, Expense 18.5M USD +36%
Interest Expense 17.8M USD +127%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%